10x Genomics, Inc. Restructuring Costs
10x Genomics, Inc. (TXG) reported Restructuring Costs of $2.50 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-02-13
- 10x Genomics, Inc. restructuring costs for the quarter ending 2022-12-31 was $3.44M.
- 10x Genomics, Inc. restructuring costs for the quarter ending 2022-09-30 was $4.20M.
- 10x Genomics, Inc. restructuring costs for fiscal 2023 was $2.50M, a 40.48% decline from fiscal 2022.
- 10x Genomics, Inc. restructuring costs for fiscal 2022 was $4.20M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.50M 10-K · filed 2026-02-13 | |||
| 2022-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $7.64M derived: sum of 2 quarters · filed 2025-02-13 | $4.20M 10-K · filed 2025-02-13 | |
| 2022-09-30 | $4.20M 10-Q · filed 2022-11-03 | $762.00K 10-Q · filed 2022-11-03 |